Inmune Bio, Inc. — Form D
Inmune Bio, Inc. of La Jolla, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-07-13. The offering totals $5.0M, of which $3.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-07-13
- Form: D
- Accession: 0001213900-17-007522
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.3M
- Remaining: $1.7M
- Minimum investment: $10K
- Investors: 29
- Date of first sale: 2017-03-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-290643
Issuer
- Name: Inmune Bio, Inc.
- CIK: 0001711754
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2015
- Address: 1224 Prospect Street, Suite 150, La Jolla, CA, 92037
- Phone: (858) 964-3720
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Terry R Knapp | Director | La Jolla, CA |
| Mark J Lowdell | Director | La Jolla, CA |
| David J Moss | Director | La Jolla, CA |
| Raymond J Tesi | Director | La Jolla, CA |
| Raymond J Tesi | Executive Officer | La Jolla, CA |
| David J Moss | Executive Officer | La Jolla, CA |
| Mark J Lowdell | Executive Officer | La Jolla, CA |
| J. Kelly Ganjei | Director | La Jolla, CA |
| Timothy Kelly Schroeder | Director | La Jolla, CA |
| David Kelly Szymkowski | Director | La Jolla, CA |
| Scott Kelly Juda | Director | La Jolla, CA |
Other filings by this issuer (1)
More